loading
Schlusskurs vom Vortag:
$2.53
Offen:
$2.52
24-Stunden-Volumen:
348.01K
Relative Volume:
0.25
Marktkapitalisierung:
$564.87M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-283.26M
KGV:
-1.2487
EPS:
-1.89
Netto-Cashflow:
$-273.61M
1W Leistung:
-8.92%
1M Leistung:
-39.97%
6M Leistung:
-71.58%
1J Leistung:
-41.17%
1-Tages-Spanne:
Value
$2.345
$2.60
1-Wochen-Bereich:
Value
$2.29
$2.65
52-Wochen-Spanne:
Value
$2.29
$12.00

Sana Biotechnology Inc Stock (SANA) Company Profile

Name
Firmenname
Sana Biotechnology Inc
Name
Telefon
(206) 701-7914
Name
Adresse
188 EAST BLAINE STREET, SUITE 400, SEATTLE
Name
Mitarbeiter
328
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-06
Name
Neueste SEC-Einreichungen
Name
SANA's Discussions on Twitter

Vergleichen Sie SANA mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
SANA 2.35 564.87M 0 -283.26M -273.61M -1.89
VRTX 446.48 115.74B 10.63B -479.80M -1.35B 13.33
REGN 740.49 81.65B 13.85B 4.65B 3.32B 35.06
ARGX 591.15 34.86B 1.86B -40.29M -1.28B -4.16
ALNY 249.56 32.09B 2.09B -332.26M 16.06M -4.14
BNTX 103.47 24.49B 3.30B -501.07M 1.03B 11.54

Sana Biotechnology Inc Stock (SANA) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-01-16 Hochstufung H.C. Wainwright Neutral → Buy
2023-09-25 Eingeleitet JMP Securities Mkt Outperform
2023-09-05 Eingeleitet Citigroup Buy
2023-08-14 Eingeleitet TD Cowen Market Perform
2023-05-02 Eingeleitet H.C. Wainwright Neutral
2021-03-01 Eingeleitet BofA Securities Buy
2021-03-01 Eingeleitet Goldman Neutral
2021-03-01 Eingeleitet JP Morgan Neutral
2021-03-01 Eingeleitet Morgan Stanley Overweight
Alle ansehen

Sana Biotechnology Inc Aktie (SANA) Neueste Nachrichten

pulisher
Nov 20, 2024

Flagship Pioneering Appoints Angela Hwang as CEO-Partner and Chief Executive Officer of Metaphore Biotechnologies - Quantisnow

Nov 20, 2024
pulisher
Nov 19, 2024

Sana Biotechnology: The Story Becomes Murkier (NASDAQ:SANA) - Seeking Alpha

Nov 19, 2024
pulisher
Nov 18, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sana Biotechnology, Inc.SANA - PR Newswire

Nov 18, 2024
pulisher
Nov 18, 2024

Sana Biotechnology (NASDAQ:SANA) Reaches New 1-Year LowHere's Why - MarketBeat

Nov 18, 2024
pulisher
Nov 18, 2024

Layoff Tracker: Adaptimmune Downsizes by 33% in Strategic Realignment - BioSpace

Nov 18, 2024
pulisher
Nov 13, 2024

10 Stocks Jeff Bezos Is Buying | Investing - U.S News & World Report Money

Nov 13, 2024
pulisher
Nov 13, 2024

Sana Biotechnology's SWOT analysis: stock outlook amid strategic pivot - Investing.com India

Nov 13, 2024
pulisher
Nov 13, 2024

Flagship Pioneering Appoints Craig Williams as CEO-Partner and Chief Executive Officer of Apriori Bio - Quantisnow

Nov 13, 2024
pulisher
Nov 13, 2024

Sana Biotechnology, Inc. (NASDAQ:SANA) Holdings Lowered by Baillie Gifford & Co. - MarketBeat

Nov 13, 2024
pulisher
Nov 13, 2024

Sana Biotechnology stock hits 52-week low at $2.75 By Investing.com - Investing.com Australia

Nov 13, 2024
pulisher
Nov 12, 2024

FMR LLC's Strategic Acquisition of Sana Biotechnology Inc Shares - GuruFocus.com

Nov 12, 2024
pulisher
Nov 12, 2024

Sana Biotechnology stock hits 52-week low at $2.75 - Investing.com India

Nov 12, 2024
pulisher
Nov 12, 2024

Sana Biotech sustains stock target with Buy rating on Q3 earnings - Investing.com Nigeria

Nov 12, 2024
pulisher
Nov 12, 2024

Analyst keeps Buy on Sana Biotechnology, adjusts outlook as blood cancer competition rises - Investing.com Canada

Nov 12, 2024
pulisher
Nov 12, 2024

Sana Biotechnology's SWOT analysis: stock outlook amid strategic pivot By Investing.com - Investing.com Canada

Nov 12, 2024
pulisher
Nov 11, 2024

Sana Biotechnology (NASDAQ:SANA) Hits New 1-Year LowWhat's Next? - MarketBeat

Nov 11, 2024
pulisher
Nov 11, 2024

Sana Biotechnology Inc Still Hasn’t Convinced Analysts? - Stocks Register

Nov 11, 2024
pulisher
Nov 11, 2024

HC Wainwright Reaffirms "Buy" Rating for Sana Biotechnology (NASDAQ:SANA) - MarketBeat

Nov 11, 2024
pulisher
Nov 09, 2024

Sana Biotechnology downgraded to Market Perform from Outperform at JMP Securities - MSN

Nov 09, 2024
pulisher
Nov 08, 2024

Sana Biotechnology, Inc. Reports Q3 2024 Financial Results - TipRanks

Nov 08, 2024
pulisher
Nov 08, 2024

Sana: Q3 Earnings Snapshot - The Washington Post

Nov 08, 2024
pulisher
Nov 08, 2024

Sana Biotechnology Inc. (SANA) Quarterly 10-Q Report - Quartzy

Nov 08, 2024
pulisher
Nov 08, 2024

Earnings Flash (SANA) SANA BIOTECHNOLOGY Reports Q3 Loss $-0.27 Per Share - Marketscreener.com

Nov 08, 2024
pulisher
Nov 08, 2024

Sana Biotechnology Reports Third Quarter 2024 Financial Results and Business Updates - The Manila Times

Nov 08, 2024
pulisher
Nov 08, 2024

HC Wainwright Issues Positive Estimate for SANA Earnings - Defense World

Nov 08, 2024
pulisher
Nov 07, 2024

HC Wainwright Issues Optimistic Forecast for SANA Earnings - MarketBeat

Nov 07, 2024
pulisher
Nov 05, 2024

Sana Biotechnology refocuses on autoimmune and diabetes therapies By Investing.com - Investing.com Australia

Nov 05, 2024
pulisher
Nov 05, 2024

Sana lowered to market perform by JMP over data uncertainty - MSN

Nov 05, 2024
pulisher
Nov 05, 2024

Sana Biotechnology (NASDAQ:SANA) Hits New 52-Week Low on Analyst Downgrade - MarketBeat

Nov 05, 2024
pulisher
Nov 05, 2024

Sana Biotechnology (NASDAQ:SANA) Price Target Lowered to $8.00 at HC Wainwright - MarketBeat

Nov 05, 2024
pulisher
Nov 05, 2024

Sana Biotechnology stock hits 52-week low at $3.05 - Investing.com

Nov 05, 2024
pulisher
Nov 05, 2024

Sana to lay off staff, deepen autoimmune focus in latest retrenchment - BioPharma Dive

Nov 05, 2024
pulisher
Nov 05, 2024

500: Something went wrong - Investing.com UK

Nov 05, 2024
pulisher
Nov 05, 2024

Sana Biotechnology stock hits 52-week low at $3.05 By Investing.com - Investing.com Canada

Nov 05, 2024
pulisher
Nov 05, 2024

JMP Securities Downgrades Sana Biotechnology (NASDAQ:SANA) to Market Perform - MarketBeat

Nov 05, 2024
pulisher
Nov 05, 2024

Vanguard Group Inc's Strategic Acquisition of Sana Biotechnology Inc Shares - GuruFocus.com

Nov 05, 2024
pulisher
Nov 04, 2024

Sana Biotechnology refocuses on autoimmune and diabetes therapies - Investing.com

Nov 04, 2024
pulisher
Nov 04, 2024

Sana Biotechnology Announces Increased Focus on Type 1 - GlobeNewswire

Nov 04, 2024
pulisher
Oct 29, 2024

Sana Biotechnology (NASDAQ:SANA) Stock Price Down 6.6%Here's Why - MarketBeat

Oct 29, 2024
pulisher
Oct 28, 2024

Sana Biotechnology (NASDAQ:SANA) Shares Up 7.7%Still a Buy? - MarketBeat

Oct 28, 2024
pulisher
Oct 21, 2024

Sana Biotechnology (NASDAQ:SANA) Stock Price Down 6.4%What's Next? - MarketBeat

Oct 21, 2024
pulisher
Oct 21, 2024

Critical Comparison: Sana Biotechnology (NASDAQ:SANA) & SAB Biotherapeutics (NASDAQ:SABS) - Defense World

Oct 21, 2024
pulisher
Oct 18, 2024

Is Sana Biotechnology (NASDAQ:SANA) In A Good Position To Deliver On Growth Plans? - Yahoo Finance

Oct 18, 2024
pulisher
Oct 16, 2024

Why Sana Biotechnology, Inc. (SANA) is the Penny Stock with the Biggest Upside Potential According to Analysts - Insider Monkey

Oct 16, 2024
pulisher
Oct 16, 2024

Biotech stock tumbles after unexplained 1,446% gain - MSN

Oct 16, 2024
pulisher
Oct 15, 2024

Sana Biotechnology Inc (SANA) looking to reclaim success with recent performance - SETE News

Oct 15, 2024
pulisher
Oct 14, 2024

Sana Biotechnology Inc [SANA] Stock sold by Insider Mulligan Richard for $0.61 million - Knox Daily

Oct 14, 2024
pulisher
Oct 14, 2024

Market Insights: Sana Biotechnology Inc (SANA)’s Notable Gain of 4.18, Closing at 3.99 - The Dwinnex

Oct 14, 2024
pulisher
Oct 14, 2024

Sana Biotechnology Inc (SANA)’s stock price in review: A technical analysis - US Post News

Oct 14, 2024
pulisher
Oct 13, 2024

Sana Biotechnology, Inc. (SANA): Jeff Bezos Is Buying This Stock Now - Insider Monkey

Oct 13, 2024

Finanzdaten der Sana Biotechnology Inc-Aktie (SANA)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Sana Biotechnology Inc-Aktie (SANA) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Mulligan Richard
Director
Sep 24 '24
Sale
4.08
150,000
612,570
2,848,121
Mulligan Richard
Director
Sep 25 '24
Sale
3.89
150,000
583,170
2,698,121
$70.68
price down icon 0.42%
$18.62
price up icon 0.16%
$36.06
price down icon 1.68%
$364.60
price up icon 0.01%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Kapitalisierung:     |  Volumen (24h):